MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Screening study of COL6A3 in sporadic isolated dystonia

L.Y. Ma, T. Feng (Beijing, China)

Meeting: 2018 International Congress

Abstract Number: 710

Keywords: Dystonia: Genetics

Session Information

Date: Sunday, October 7, 2018

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To verify the role of COL6A3 in isolated dystonia.

Background: COL6A3 has recently been suggested to cause a form of autosomal recessive isolated dystonia. Until now, there is limited information about Col6A3 gene test in Asian population. Herein, we performed comprehensive COL6A3 mutation screenings in 179 sporadic isolated dystonia patients from Chinese population, including 57 early-onset cases.

Methods: We collected blood samples and used Polymerase chain reactions (PCR) to amplify 43 coding exons and intron 41 of COL6A3 (NM_004369.3). Mutational screening was performed by direct sequencing. All patients were negative for the genetic testing of TOR1A, THAP1, CIZ1, GNAL and ANO3.

Results: None of the reported disease-causing mutations were found. As a result, we identified one patient with compound heterozygotes of maternal and paternal origin (c.5000A>G[p.D1667G] and c.7570C>T[p.P2524S](Fig 1). Bioinformatics analysis demonstrated that both variants exhibit highly conserved residues across species. Structural analysis revealed hydrogen bonding interaction disruption in D1667G and free energy increase in P2524S. Besides, 8 other variants were found in 8 dystonia patients separately.

Conclusions: Our study revealed that mutation in COL6A3 is not a major cause of sporadic isolated dystonia, at least in Chinese population. Functional analysis D1667G and P2524S and validation in a larger study from a more diverse ethnic population are needed to ascertain the role of COL6A3.

References: [1] Zech M, Lam DD, Francescatto L, et al. Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia. Am J Hum Genet. 2015. 96(6): 883-93. [2] Lohmann K, Schlicht F, Svetel M, et al. The role of mutations in COL6A3 in isolated dystonia. J Neurol. 2016. 263(4): 730-4. [3] Bönnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011. 7(7): 379-90.

To cite this abstract in AMA style:

L.Y. Ma, T. Feng. Screening study of COL6A3 in sporadic isolated dystonia [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/screening-study-of-col6a3-in-sporadic-isolated-dystonia/. Accessed July 6, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/screening-study-of-col6a3-in-sporadic-isolated-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley